• Why Choose Us
    • History
    • News
    • Industry Insights
      • Therapeutic Commercialization
      • Sourcing Radiopharmaceuticals
      • Radiopharmaceutical Trends
    • Our Partnerships
  • Product Portfolio
    • PET Products
    • SPECT Products
    • Radioligland Therapies
    • Ancillary Products
  • Our Network
  • Learning Center
  • Careers
  • Order Online
  • Radiopharmacies Division
    • Radiopharmaceuticals Division
    • Radiopharmacies Division
  • Radiopharmacies Division3
    • Radiopharmaceuticals Division
    • Radiopharmacies Division
5 Trends in Radiopharmaceuticals: What’s Changing and Why It Matters

5 Trends in Radiopharmaceuticals: What’s Changing and Why It Matters

Jul 15, 2025 | Industry Insights

Recent Posts

  • 5 Trends in Radiopharmaceuticals: What’s Changing and Why It Matters
  • Jubilant Radiopharma and Simplified Imaging Solutions Announce Strategic Partnership to Support the Nuclear Medicine Community
  • Life Molecular Imaging and Jubilant Radiopharma announce Neuraceq® availability in Mobile, AL
  • Jubilant Radiopharma Announces Investment of $50 million (USD) to Expand Positron Emission Tomography (PET) Manufacturing Network
  • Jubilant awarded Radiopharmaceutical Group Purchasing Agreement by Premier

Connect With Us

Corporate Headquarters

      
Jubilant Radiopharmacies Division
790 Township Line Road, Suite 325,
Yardley, PA 19067, USA

 

 215 550 2810

Why Choose Us

Products

Our Network

Patient Notice of Privacy Practices

Learning Center

Careers

Privacy Policy

Code of Conduct

Disclaimer

© 2026 Jubilant Draximage, Inc. dba Jubilant Radiopharma™ A Jubilant Pharma Company

Privacy Policy

Code of Conduct

Disclaimer

© 2026 Jubilant Draximage, Inc. dba Jubilant Radiopharma™ A Jubilant Pharma Company